This possibility was later confirmed by seminal studies showing that IL7R gain-of-function somatic mutations occur in around 10% of T-ALL and 1% of BCP-ALL patients at diagnosis [247,248]. Here, IL7R is linked to acute lymphoblastic leukemia.